After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
KROS belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Keros Therapeutics Inc is $570.24M. A total of 0.63 million shares were traded on the day, compared to an average of 1.06M shares.
In the most recent transaction, ADAR1 Capital Management, LLC bought 934,258 shares of KROS for 10.13 per share on Apr 09 ’25. After the transaction, the 10% Owner now owns 4,392,737 company shares. In a previous transaction on Aug 13 ’24, GORDON CARL L sold 250,000 shares at 44.01 per share. KROS shares that Director owns now total 119,522.
Among the insiders who sold shares, ORBIMED ADVISORS LLC disposed of 250,000 shares on Aug 13 ’24 at a per-share price of $44.01. This resulted in the Director holding 119,522 shares of KROS after the transaction. In another insider transaction, OrbiMed Genesis Master Fund, L bought 29,400 shares at $44.84 per share on Aug 13 ’24.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, KROS has a high of $72.37 and a low of $9.12.
As of this writing, KROS has an earnings estimate of -$1.13 per share for the current quarter. EPS was calculated based on a consensus of 6.0 estimates, with a high estimate of -$0.89 per share and a lower estimate of -$1.3.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. KROS’s latest balance sheet shows that the firm has $230.04M in Cash & Short Term Investments as of fiscal 2021. There were $1.09M in debt and $11.85M in liabilities at the time. Its Book Value Per Share was $17.97, while its Total Shareholder’s Equity was $243.17M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock.
